Company Comparison
BioPharma Nexus vs 10x Genomics
Side-by-side comparison of two portfolio companies — sector, funding stage, investors, valuation, and more.
| Metric | BioPharma Nexus | 10x Genomics |
|---|---|---|
| Sector | Biotech | Biotech |
| Headquarters | Cambridge | — |
| Founded | — | — |
| Status | Active | Active |
| Last Funding Stage | Pre-Seed | — |
| Total Funding | $2.8M | — |
| Valuation | — | — |
What They Build
BioPharma Nexus
An early-stage Cambridge biotech company serving as a nexus in the biopharmaceutical industry with $2.8M pre-seed funding.
10x Genomics
10x Genomics, Inc. is an American biotechnology company that designs and manufactures sequencing technologies for use in scientific research, with a focus on product development for single-cell and spatial omics.
Key Investors
BioPharma Nexus
No investors listed.
Sector Overlap
Both BioPharma Nexus and 10x Genomics operate in Biotech.
Browse all Biotech companies →